Squamous cell carcinoma of the lung is linked to smoking and requires early detection and accurate staging for effective treatment. Diagnosis involves imaging and biopsy, with the TNM system used to ...
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the Saudi Food and Drug ...
Stocktwits on MSN
IBRX garners retail attention on positive update in immunotherapy for lung cancer patients
The company said that responding patients lived longer overall, with a median survival of 16.2 months. ・The data come from ...
ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced positive results from its ANKTIVA ...
Large cell carcinoma is aggressive, requiring early detection through imaging and biopsy for optimal treatment outcomes.
The emergence of next-generation KRAS G12C inhibitors has led Verastem Oncology to change course. | The emergence of next-generation KRAS G12C inhibitors has led Verastem Oncology to change course.
An FDA approval is setting a new benchmark for future treatment for first-line small cell lung cancer. The FDA has greenlighted Jazz Pharmaceuticals’ Zepzelca, used in combination with Roche’s ...
Lung-on-chip model made of cells derived from a single person furthers understanding of tuberculosis and potential ...
We currently know that COPD, and specifically emphysema, is not just a lung disease found alongside lung cancer; it increases ...
Radon and smoking are both known causes of lung cancer, but when someone is exposed to both, the results can be deadly.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback